The Middle Eastern stock markets exhibited mixed results, with Egypt’s bourse standing out by outperforming many of its Gulf counterparts in 2025. Meanwhile, the Saudi market faced headwinds, primarily due to fluctuating oil prices that impacted investor sentiment and overall performance. Amidst these market dynamics, the concept of “penny stocks” has garnered renewed interest. Despite often being associated with lower-quality investments, penny stocks can present significant opportunities for savvy investors looking to capitalize on smaller or emerging companies with solid financial underpinnings.
Investors keen on penny stocks should consider those with strong financial health ratings. For instance, Thob Al Aseel listed on the Saudi Exchange is trading at SAR 3.35, holding a market cap of SAR 1.35 billion, and enjoys a financial health rating of six stars. Other noteworthy mentions include Alarum Technologies, with a share price of ₪2.811 and a market cap of ₪201.59 million, and E7 Group PJSC, priced at AED 1.04 with a market cap of AED 2.18 billion, both holding a solid financial health rating.
Ajman Bank PJSC, which serves individuals, businesses, and government entities in the UAE, has a market cap of AED 3.58 billion. The bank primarily earns its revenue from wholesale banking, followed by consumer banking and treasury operations. Despite facing challenges such as a high bad loans ratio of 8.9%, it has shown profitability with a loans-to-deposits ratio of 69% and a price-to-earnings ratio of 7.3x that suggests it might be undervalued. The bank’s experienced management supports stable earnings growth, complemented by a return on equity of 14.6%.
In Saudi Arabia, Arabian Pipes Company operates in the steel industry, with a market cap of SAR 946 million. It has experienced a decline in both sales and net income over the past year, yet it maintains a favorable price-to-earnings ratio of 8.2x. The company’s operating cash flow significantly covers its short-term debts, and it has a robust return on equity of 23.9%, although profit margins have decreased.
Another company to watch is Novolog (Pharm-Up 1966) Ltd, a player in Israel’s healthcare sector with a market capitalization of ₪641.66 million. Novolog recently became profitable, although it has seen deteriorating earnings over the past five years. The company’s debt is adequately covered by its operating cash flow, showcasing good liquidity, yet its dividend yield of 3.12% raises concerns regarding sustainability given the current earnings pressures.
Investors are encouraged to perform thorough due diligence, especially within the penny stock segment, as opportunities can arise even in challenging economic climates. Staying informed about financial health ratings, revenue stability, and market conditions can further aid in making sound investment decisions within this evolving landscape.
